- Home
- ELUT vs MNOV Comparison
ELUT vs MNOV Comparison
Compare ELUT & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELUT
- MNOV
- Stock Information
- Founded
- ELUT 2015
- MNOV 2000
- Country
- ELUT United States
- MNOV United States
- Employees
- ELUT N/A
- MNOV N/A
- Industry
- ELUT Medical Specialities
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- ELUT Health Care
- MNOV Health Care
- Exchange
- ELUT Nasdaq
- MNOV Nasdaq
- Market Cap
- ELUT 79.7M
- MNOV 65.7M
- IPO Year
- ELUT 2020
- MNOV 2005
- Fundamental
- Price
- ELUT $1.28
- MNOV $1.23
- Analyst Decision
- ELUT Strong Buy
- MNOV Strong Buy
- Analyst Count
- ELUT 2
- MNOV 2
- Target Price
- ELUT $7.00
- MNOV $7.00
- AVG Volume (30 Days)
- ELUT 181.4K
- MNOV 65.0K
- Earning Date
- ELUT 11-13-2025
- MNOV 11-12-2025
- Dividend Yield
- ELUT N/A
- MNOV N/A
- EPS Growth
- ELUT N/A
- MNOV N/A
- EPS
- ELUT N/A
- MNOV N/A
- Revenue
- ELUT $23,683,000.00
- MNOV $134,599.00
- Revenue This Year
- ELUT $19.68
- MNOV N/A
- Revenue Next Year
- ELUT $70.28
- MNOV N/A
- P/E Ratio
- ELUT N/A
- MNOV N/A
- Revenue Growth
- ELUT N/A
- MNOV N/A
- 52 Week Low
- ELUT $1.28
- MNOV $1.13
- 52 Week High
- ELUT $5.12
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- ELUT 26.11
- MNOV 37.77
- Support Level
- ELUT $2.18
- MNOV $1.25
- Resistance Level
- ELUT $2.38
- MNOV $1.38
- Average True Range (ATR)
- ELUT 0.20
- MNOV 0.05
- MACD
- ELUT -0.11
- MNOV -0.01
- Stochastic Oscillator
- ELUT 0.00
- MNOV 0.00
About ELUT Elutia Inc.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.